Parallel Advisors’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.5M | Sell |
2,664
-33
| -1% | -$21.2K | 0.03% | 358 |
|
|
2025
Q4 | $1.82M | Buy |
2,697
+100
| +4% | +$68.1K | 0.03% | 311 |
|
|
2025
Q3 | $1.66M | Buy |
2,597
+28
| +1% | +$17K | 0.03% | 315 |
|
|
2025
Q2 | $1.38M | Sell |
2,569
-39
| -1% | -$18.6K | 0.03% | 340 |
|
|
2025
Q1 | $1.1M | Buy |
2,608
+61
| +2% | +$26.5K | 0.02% | 379 |
|
|
2024
Q4 | $1.05M | Sell |
2,547
-91
| -3% | -$39.9K | 0.02% | 385 |
|
|
2024
Q3 | $1.33M | Buy |
2,638
+43
| +2% | +$20.9K | 0.03% | 319 |
|
|
2024
Q2 | $1.26M | Buy |
2,595
+26
| +1% | +$13.1K | 0.03% | 315 |
|
|
2024
Q1 | $1.39M | Buy |
2,569
+271
| +12% | +$148K | 0.04% | 291 |
|
|
2023
Q4 | $1.28M | Buy |
2,298
+43
| +2% | +$20.2K | 0.04% | 293 |
|
|
2023
Q3 | $986K | Sell |
2,255
-12
| -0.5% | -$5.98K | 0.03% | 315 |
|
|
2023
Q2 | $1.14M | Sell |
2,267
-7
| -0.3% | -$3.35K | 0.04% | 297 |
|
|
2023
Q1 | $1.14M | Buy |
2,274
+49
| +2% | +$23.4K | 0.04% | 290 |
|
|
2022
Q4 | $908K | Buy |
2,225
+68
| +3% | +$26.4K | 0.04% | 276 |
|
|
2022
Q3 | $703K | Buy |
2,157
+76
| +4% | +$27.9K | 0.03% | 302 |
|
|
2022
Q2 | $730K | Sell |
2,081
-139
| -6% | -$56.7K | 0.03% | 299 |
|
|
2022
Q1 | $1.22M | Buy |
2,220
+9
| +0.4% | +$4.73K | 0.05% | 238 |
|
|
2021
Q4 | $1.46M | Sell |
2,211
-16
| -0.7% | -$10K | 0.05% | 213 |
|
|
2021
Q3 | $1.39M | Buy |
2,227
+51
| +2% | +$34.3K | 0.06% | 213 |
|
|
2021
Q2 | $1.37M | Buy |
2,176
+96
| +5% | +$53K | 0.06% | 211 |
|
|
2021
Q1 | $1.02M | Buy |
2,080
+109
| +6% | +$54.6K | 0.05% | 228 |
|
|
2020
Q4 | $985K | Sell |
1,971
-74
| -4% | -$33.1K | 0.05% | 213 |
|
|
2020
Q3 | $804K | Buy |
2,045
+133
| +7% | +$49.2K | 0.05% | 211 |
|
|
2020
Q2 | $631K | Buy |
1,912
+7
| +0.4% | +$2.03K | 0.04% | 254 |
|
|
2020
Q1 | $461K | Buy |
1,905
+101
| +6% | +$26.4K | 0.04% | 264 |
|
|
2019
Q4 | $471K | Hold |
1,804
| – | – | 0.04% | 299 |
|
|
2019
Q3 | $491K | Sell |
1,804
-193
| -10% | -$53.7K | 0.04% | 271 |
|
|
2019
Q2 | $550K | Hold |
1,997
| – | – | 0.05% | 223 |
|
|
2019
Q1 | $447K | Sell |
1,997
-15
| -0.7% | -$3.1K | 0.05% | 238 |
|
|
2018
Q4 | $374K | Sell |
2,012
-8
| -0.4% | -$1.64K | 0.05% | 241 |
|
|
2018
Q3 | $504K | Hold |
2,020
| – | – | 0.06% | 205 |
|
|
2018
Q2 | $440K | Sell |
2,020
-12
| -0.6% | -$2.47K | 0.06% | 200 |
|
|
2018
Q1 | $389K | Sell |
2,032
-216
| -10% | -$39.9K | 0.06% | 206 |
|
|
2017
Q4 | $352K | Hold |
2,248
| – | – | 0.06% | 221 |
|
|
2017
Q3 | $332K | Sell |
2,248
-6
| -0.3% | -$949 | 0.06% | 230 |
|
|
2017
Q2 | $375K | Hold |
2,254
| – | – | 0.07% | 203 |
|
|
2017
Q1 | $361K | Sell |
2,254
-801
| -26% | -$110K | 0.07% | 197 |
|
|
2016
Q4 | $358K | Buy |
+3,055
| New | +$349K | 0.08% | 169 |
|
Other funds holding IDXX
VCM
VPM
Parallel Advisors's IDXX Position: Q1 2026 in Review
Parallel Advisors reduced its Idexx Laboratories (IDXX) stake by 1.2% in Q1 2026, selling an estimated $21.2K and leaving 2,664 shares worth $1.5M. The position accounts for 0.03% of the portfolio, ranked #358.
Parallel Advisors first reported a position in IDXX in Q4 2016 and has held it in 38 quarters since. The position peaked at $1.82M in Q4 2025. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.
- Parallel Advisors held 2,664 shares of Idexx Laboratories worth $1.5M as of Q1 2026.
- Parallel Advisors sold 33 Idexx Laboratories shares in Q1 2026, an estimated $21.2K.
- Idexx Laboratories made up 0.03% of Parallel Advisors's portfolio in Q1 2026, its #358 holding.
- Parallel Advisors first reported a position in Idexx Laboratories in Q4 2016 and has held it in 38 quarters since.
- Parallel Advisors's Idexx Laboratories position peaked at $1.82M in Q4 2025.
- 1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.
Based on Parallel Advisors's 13F filing for Q1 2026, filed 7 May 2026.